Bioatla Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
BCAB Nasdaq 8731 https://www.bioatla.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bioatla Inc

BioAtla, Inc. (NASDAQ:BCAB) Q4 2022 Earnings Call Transcript - Mar 27th, 2023 11:12 am
Q4 2022 Bioatla Inc Earnings Call - Mar 24th, 2023 3:31 pm
BioAtla Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Progress - Mar 23rd, 2023 8:05 pm
BioAtla to Announce Fourth Quarter and Full-Year 2022 Financial Results and Provide Business Highlights - Mar 16th, 2023 12:00 pm
BioAtla Announces Change in Executive Leadership - Feb 27th, 2023 1:07 pm
BioAtla Announces FDA Clearance of Investigational New Drug Application for BA3182, a CAB-EpCAMxCAB-CD3 Bispecific T-Cell Engager for the Treatment of Advanced Adenocarcinoma - Feb 23rd, 2023 1:00 pm
Recent uptick might appease BioAtla, Inc. (NASDAQ:BCAB) institutional owners after losing 56% over the past year - Jan 25th, 2023 12:10 pm
BioAtla Provides Clinical Program Updates and Upcoming 2023 Milestones - Jan 10th, 2023 1:00 pm
Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney to the Company's Board of Directors - Dec 29th, 2022 9:05 pm
BioAtla to Participate in the 41st Annual J.P. Morgan Healthcare Conference - Dec 22nd, 2022 1:00 pm
BioAtla, Inc.'s stock is down 11%, but insiders still have about US$393k in profit after buying earlier this year - Dec 8th, 2022 1:54 pm
Does BioAtla, Inc. (BCAB) Have the Potential to Rally 114% as Wall Street Analysts Expect? - Dec 1st, 2022 2:55 pm
Can BioAtla, Inc. (BCAB) Climb 260% to Reach the Level Wall Street Analysts Expect? - Nov 15th, 2022 2:55 pm
Companies Like BioAtla (NASDAQ:BCAB) Are In A Position To Invest In Growth - Nov 11th, 2022 1:38 pm
BioAtla to Participate in the Jefferies London Healthcare Conference - Nov 8th, 2022 1:00 pm
BioAtla, Inc. (BCAB) Reports Q3 Loss, Lags Revenue Estimates - Nov 4th, 2022 3:15 pm
BioAtla Announces $65 Million Underwritten Offering of its Common Stock - Nov 4th, 2022 1:08 pm
BioAtla Reports Third Quarter 2022 Financial Results and Highlights Recent Progress - Nov 3rd, 2022 8:01 pm
BioAtla to Announce Third Quarter 2022 Financial Results and Provide Business Highlights on November 3, 2022 - Oct 27th, 2022 12:00 pm
Australian Billionaire Kerr Neilson is Selling These 15 Stocks - Sep 23rd, 2022 1:15 pm